chemie.pr-OnVista: PROGENICS PHARM (910678,US7431871067) - Aktienanalyse - News ...
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
24.04.2008 22:40:06
Wyeth Pharmaceuticals: COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24
(ots/PRNewswire) -- - Final Decision from European Commission Expected by Mid-2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
- European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naïve Adults With HIV-1
- INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for Treatment of HIV
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
- New Biologic Ustekinumab Receives Positive Opinion From European Regulatory Authority for the Treatment of Moderate to Severe Plaque Psoriasis
- Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer
- European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
- More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
- European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
- Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness
Ground Zero Pharmaceuticals gibt Erweiterung der ...
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness
News zu Wirtschaft, Politik, Finanzen, Gesundheit und Gold
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness
Bankkaufmann - News
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness